|1||NCT02374567||Terminated||Pharmacovigilance in Gerontopsychiatric Patients||
||407||All||65 Years and older (Older Adult)||NCT02374567||GAP-2014||GAP||January 2015||June 28, 2017||June 28, 2017||March 2, 2015||February 28, 2018||
|Efficacy and Safety Study of a Combination Product [Drug:BCI-024 (Buspirone) and Drug:BCI-049 (Melatonin)] to Treat Major Depressive Disorder (MDD)||
||Other / Industry||
||142||All||18 Years to 65 Years (Adult, Older Adult)||NCT00705003||CBM-IT-01||May 2008||December 2008||December 2008||June 25, 2008||June 18, 2014||June 18, 2014||
† Study has passed its completion date and status has not been verified in more than two years.